1369. Combined Analysis of the In Vitro Activity of Ridinilazole (RDZ) Against More Than 500 Clostridium difficile (CD) Clinical Isolates and Impact of RDZ on Cell Morphology

BACKGROUND: Clostridium difficile infection (CDI) is one of the most urgent bacterial healthcare threats in the United States. RDZ is a targeted spectrum, GI restricted, antibacterial currently in clinical development for the treatment of CDI and reducing the recurrence of CDI. Here we report the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Duperchy, Esther, Bassères, Eugénie, Garey, Kevin, Vickers, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252952/
http://dx.doi.org/10.1093/ofid/ofy210.1200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252952/
http://dx.doi.org/10.1093/ofid/ofy210.1200

Ejemplares similares